bupropion and s20098

bupropion has been researched along with s20098 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Humpston, CS; Robinson, ES; Wood, CM1
Bleich, S; Correll, C; Eberlein, CK; Frieling, H; Kahl, KG; Pul, R; Sühs, KW1
Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E1
Larsen, ER; Roopan, S1

Reviews

1 review(s) available for bupropion and s20098

ArticleYear
Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review.
    Acta neuropsychiatrica, 2017, Volume: 29, Issue:3

    Topics: Acetamides; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Comorbidity; Depression; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hyperglycemia; Hypnotics and Sedatives; Hypoglycemia; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Young Adult

2017

Other Studies

3 other study(ies) available for bupropion and s20098

ArticleYear
Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:2

    Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Choice Behavior; Cyclobutanes; Cyclohexanols; Fluoxetine; Hypnotics and Sedatives; Idazoxan; Impulsive Behavior; Male; Norepinephrine; Paroxetine; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2013
Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.
    Brain and behavior, 2015, Volume: 5, Issue:4

    Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2015
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
    Expert review of pharmacoeconomics & outcomes research, 2017, Volume: 17, Issue:3

    Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine

2017